🍂 Enjoy the Fall Season! 🍂
MindTheDesk

A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled

Business Archived • November 3, 2026 • 3 views
A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled
Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
Source: CNBC Top | https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original
"Adventure is where you chose to go."

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Monetize your website or boost your business with Code-Oryx. Join the network today!"
"Retirement Health Care"